125 related articles for article (PubMed ID: 2117268)
1. Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells.
Prezioso JA; Fitzgerald GB; Wick MM
Pigment Cell Res; 1990; 3(2):49-54. PubMed ID: 2117268
[TBL] [Abstract][Full Text] [Related]
2. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells.
Prezioso JA; Epperly MW; Wang N; Bloomer WD
Cancer Lett; 1992 Mar; 63(1):73-9. PubMed ID: 1555210
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.
Prezioso JA; FitzGerald GB; Wick MM
J Invest Dermatol; 1992 Sep; 99(3):289-93. PubMed ID: 1512464
[TBL] [Abstract][Full Text] [Related]
4. Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
Prezioso JA; Damodaran KM; Wang N; Bloomer WD
Biochem Pharmacol; 1993 Jan; 45(2):473-81. PubMed ID: 8435097
[TBL] [Abstract][Full Text] [Related]
5. Glutathione depletion increases tyrosinase activity in human melanoma cells.
del Marmol V; Solano F; Sels A; Huez G; Libert A; Lejeune F; Ghanem G
J Invest Dermatol; 1993 Dec; 101(6):871-4. PubMed ID: 7902381
[TBL] [Abstract][Full Text] [Related]
6. Potentiation by alpha-difluoromethylornithine of the activity of 3,4-dihydroxybenzylamine, a tyrosinase-dependent melanolytic agent, against B16 melanoma.
Prakash NJ; Sunkara PS; Sjoerdsma A
Biochem Pharmacol; 1985 Jun; 34(11):1887-90. PubMed ID: 3924051
[TBL] [Abstract][Full Text] [Related]
7. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
Benathan M; Alvero-Jackson H; Mooy AM; Scaletta C; Frenk E
Melanoma Res; 1992 Dec; 2(5-6):305-14. PubMed ID: 1337997
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
Thody AJ; Oliver I; Sherbet GV
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1879-84. PubMed ID: 2851444
[TBL] [Abstract][Full Text] [Related]
9. Modulation of glutathione level in cultured human melanoma cells.
Karg E; Brötell H; Rosengren E; Rorsman H
Acta Derm Venereol; 1989; 69(2):137-41. PubMed ID: 2564231
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine.
Bolognia JL; Sodi SA; Osber MP; Pawelek JM
Br J Dermatol; 1995 Sep; 133(3):349-57. PubMed ID: 8546987
[TBL] [Abstract][Full Text] [Related]
11. Long-term buthionine-sulfoximine-mediated toxicity in cultured hepatoma cell lines.
Dierickx PJ
Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):423-6. PubMed ID: 2160706
[TBL] [Abstract][Full Text] [Related]
12. 3,4-Dihydroxybenzylamine: an improved dopamine analog cytotoxic for melanoma cells in part through oxidation products inhibitory to dna polymerase.
FitzGerald GB; Wick MM
J Invest Dermatol; 1983 Feb; 80(2):119-23. PubMed ID: 6401786
[TBL] [Abstract][Full Text] [Related]
13. Non-myelotoxic antitumour effects of L-dopa, buthionine sulphoximine and tamoxifen on neuroblastoma cells in vitro and in vivo.
Busse E; Bartsch O; Kornhuber B
J Cancer Res Clin Oncol; 1991; 117(5):449-53. PubMed ID: 1653780
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs.
Thrall BD; Raha GA; Springer DL; Meadows GG
Pigment Cell Res; 1991 Dec; 4(5-6):234-9. PubMed ID: 1823927
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
Kable EP; Favier D; Parsons PG
Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
Ishikawa M; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
[TBL] [Abstract][Full Text] [Related]
17. Opposite regulation of tyrosinase and glutathione peroxidase by intracellular thiols in human melanoma cells.
Benathan M
Arch Dermatol Res; 1997 May; 289(6):341-6. PubMed ID: 9209680
[TBL] [Abstract][Full Text] [Related]
18. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.
Benathan M
Melanoma Res; 1996 Jun; 6(3):183-9. PubMed ID: 8819121
[TBL] [Abstract][Full Text] [Related]
20. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]